Neurobiological mechanisms in generalized anxiety disorder

D. J. Nutt, D. J. Stein, Y. Lecrubier, H. U. Wittchen, J. C. Ballenger, T. D. Borkovec, J. R.T. Davidson

Research output: Contribution to journalArticlepeer-review

Abstract

Generalized anxiety disorder (GAD) is a common and serious disorder. Despite this fact, there is no clear understanding of the exact neurobiological changes underlying the condition. To date, there are few studies of neurobiological function in patients with GAD, and only limited comparative data with depression are available. Advances in neuroanatomical imaging techniques are beginning to allow detailed study of regional blood flow and metabolism and may offer insights into the specific regions of the brain involved in GAD. Investigations into neurotransmitter dysfunction have implicated the γ-aminobutyric acid/benzodiazepine, serotonergic, and noradrenergic systems in this disorder. Variations in sleep patterns have also been assessed and indicate a biological separation from depression.

Original languageEnglish (US)
Pages (from-to)22-28
Number of pages7
JournalJournal of Clinical Psychiatry
Volume62
Issue numberSUPPL. 11
StatePublished - 2001

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Neurobiological mechanisms in generalized anxiety disorder'. Together they form a unique fingerprint.

Cite this